SAN FRANCISCO, May 17, 2023 /PRNewswire/ — The global cleanroom technology market size is expected to reach USD 5.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.58% from 2023 to 2030. Growing compliance with stringent regulatory standards for new product … Read more
Uniting to Combat Neglected Tropical Diseases (unitingtocombatntds.org) releases letter signed by 36 Parliamentarians from 23 countries calling on G7 Leaders to invest in NTDs. LONDON, May 17, 2023 /PRNewswire/ — To: Fumio Kishida, Prime Minister, Japan (Host) Joe Biden, President, United StatesEmmanuel Macron, President, FranceGiorgia Meloni, Prime Minister, ItalyOlaf Scholz, Chancellor, GermanyRishi Sunak, Prime Minister, … Read more
LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more
LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more
Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s report … Read more
Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s report … Read more
Evidence-based recommendations support the effective use of TOT in diabetic foot ulcer management, revolutionizing treatment approaches worldwide CAMBRIDGE, England, May 17, 2023 /PRNewswire/ — NATROX® Wound Care, a leading innovator in wound care technology, proudly announces the release of newly published expert recommendations on the use of topical oxygen therapy for wound healing1. The updated … Read more
Evidence-based recommendations support the effective use of TOT in diabetic foot ulcer management, revolutionizing treatment approaches worldwide CAMBRIDGE, England, May 17, 2023 /PRNewswire/ — NATROX® Wound Care, a leading innovator in wound care technology, proudly announces the release of newly published expert recommendations on the use of topical oxygen therapy for wound healing1. The updated … Read more
STOCKHOLM, May 17, 2023 /PRNewswire/ — FIRST QUARTER (JANUARY – MARCH 2023) Order intake SEK 206.6 M (272.5) Net sales SEK 230.2 M (208.1) Operating profit SEK 23.7 M (29.6) Profit after tax SEK 17.6 M (19.3) Earnings per share before/after dilution SEK 0.51 (0.56) Cash flow SEK 84.5 M (35.3) Order backlog SEK 1,903.3 … Read more
TAIZHOU, China, May 17, 2023 /PRNewswire/ — Jiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that, MSCI announced the results of the semi-annual review of the MSCI Global Small Cap Indexes on May 12, 2023, and the Company has been selected as a constituent of the … Read more